Consequences of patient access restrictions to branded...

Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans

Ben-Joseph, Rami, Chen, Chi-Chang, De, Ajita P., Wade, Rolin L., Shah, Dhvani
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696998.2014.925464
Date:
October, 2014
File:
PDF, 549 KB
english, 2014
Conversion to is in progress
Conversion to is failed